Invivoscribe

1.7K posts

Invivoscribe banner
Invivoscribe

Invivoscribe

@Invivoscribe

Improving lives with precision diagnostics® for informed treatment decisions in myelo- and lympho-proliferative disorders. #Oncology #MFC #NGS #ClinicalTrials

San Diego, CA, USA Katılım Mart 2010
708 Takip Edilen534 Takipçiler
Invivoscribe
Invivoscribe@Invivoscribe·
PrepQuant™: Eliminating Variability from the Start For information on availability and early access, please visit: invivoscribe.com/prepquant
Invivoscribe tweet media
English
0
0
2
26
Invivoscribe
Invivoscribe@Invivoscribe·
Invivoscribe recently launched the LeukoStrat KMT2A + MRD Assay – a single test for screening + #MRD monitoring with a 0.005% sensitivity. Globally standardized data you trust. Connect with us to learn how to accelerate your #KMT2A trials: invivoscribe.com/contact/?utm_s…
Invivoscribe tweet media
English
0
0
2
47
Invivoscribe
Invivoscribe@Invivoscribe·
Invivoscribe is excited to connect with the global pathology community at #MPAICON 2026! Connect with our experts at booth #9 to learn how we support high-quality molecular testing and impactful cancer research worldwide. hubs.li/Q043WCj20
Invivoscribe tweet media
English
0
0
1
10
Invivoscribe
Invivoscribe@Invivoscribe·
Built with customer feedback in mind, LymphoTrack Software v3.0.0 delivers meaningful enhancements in performance, customizations, and reference database integration; supporting greater accuracy in gene rearrangement analysis. Learn more: hubs.li/Q040K2df0
Invivoscribe tweet media
English
0
0
0
22
Invivoscribe
Invivoscribe@Invivoscribe·
Invivoscribe is pleased to announce the release of LymphoTrack Software v3.0.0, a powerful update developed with your feedback in mind. For more details and a preview of the updated user interface, please visit: hubs.li/Q03-p_pQ0 #Clonality #Invivoscribe
Invivoscribe tweet media
English
0
0
0
29
Invivoscribe
Invivoscribe@Invivoscribe·
Season’s greetings from Invivoscribe! As we wrap up the year, we appreciate the collaboration and shared dedication that drive meaningful progress in precision diagnostics. We wish you a wonderful holiday season and a successful year ahead.
English
0
1
4
28
Invivoscribe
Invivoscribe@Invivoscribe·
When assessing MRD, sensitivity matters. We’re excited to announce our ultra-sensitive RUO AML MRD assays and software are now under the trusted LeukoStrat brand. Learn how our MRD testing solutions enable rapid turnaround and objective meaningful results:hubs.li/Q03YGXw00
English
2
1
3
20
Invivoscribe
Invivoscribe@Invivoscribe·
Morphologic remission ≠ cure. The MORPHO trial showed that MRD-negative patients derived the greatest benefit from FLT3 inhibitor maintenance post-transplant. Learn how you can equip your team with the tools to guide smarter AML transplant decisions. ⟶ hubs.li/Q03Y8Qcq0
Invivoscribe tweet media
English
0
1
3
26
Invivoscribe
Invivoscribe@Invivoscribe·
We are excited to attend #ASH25 in Orlando! Invivoscribe’s global network of ISO 15189 laboratories offers standardized #MRD testing which can help accelerate drug development and approval timelines. Let’s connect at booth #217! hubs.li/Q03WsttZ0
Invivoscribe tweet media
English
0
0
3
44
Invivoscribe
Invivoscribe@Invivoscribe·
Thank you to everyone who stopped by poster #TT082: "The LymphoTrack Flex Assay: A High-Throughput NGS Assay for the Assessment of Clonality in Lymphoproliferative Diseases.” Presented by Angelo Arias, PhD. At the #AMPath2025 poster sessions today.
Invivoscribe tweet media
English
1
1
9
334